ANXA2P2 and cervical cancer: Next, DDP-resistant cervical cancer cells were co-transfected with si-ANXA2P2 and miR-361-3p inhibitor, exposed to 1, 2, 4, 8, 16, or 32 μg/ml DDP, and examined for cell viability.